FDA approves Cobenfy for adults with schizophrenia
The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...
Cero Therapeutics receives FDA clearance of IND application for CER-1236
CERo Therapeutics (CERO) announces that the U.S. Food and Drug Administration has cleared the Company’s Investigational New Drug ...
PharmaTher Announces Post Complete Response Letter Clarification Meeting Request Granted from the FDA for Ketamine Abbreviated New Drug Application
PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced that the Company requested a post-complete letter clarification ...
LinkedIn4d
Vadim Victor Eristavi’s Post
Many are available as lower-cost generics. - Both biologics and small molecule drugs have their place in medicine. But they’re handled differently by the FDA.